" /> Hypocalciuric hypercalcemia, familial, type I - CISMeF





Preferred Label : Hypocalciuric hypercalcemia, familial, type I;

Symbol : HHC1;

CISMeF acronym : FBH1; FHH; FHH1; HHC1;

Type : Phenotype, molecular basis known;

Alternative titles and symbols : Familial benign hypercalcemia 1; Hypercalcemia, familial benign; FHH1; FBH1; Hhc; FHH;

Included titles and symbols : Hypocalciuric hypercalcemia, acquired;

Description : Familial hypocalciuric hypercalcemia (HHC) is a heritable disorder of mineral homeostasis that is transmitted as an autosomal dominant trait with a high degree of penetrance. HHC is characterized biochemically by lifelong elevation of serum calcium concentrations and is associated with inappropriately low urinary calcium excretion and a normal or mildly elevated circulating parathyroid hormone (PTH; 168450) level. Hypermagnesemia is typically present. Individuals with HHC are usually asymptomatic and the disorder is considered benign. However, chondrocalcinosis and pancreatitis occur in some adults (summary by Hannan et al., 2010). - Genetic Heterogeneity of Hypocalciuric Hypercalcemia Familial hypocalciuric hypercalcemia type II (HHC2; 145981) is caused by mutation in the GNA11 gene (139313) on chromosome 19p13, and HHC3 (600740) is caused by mutation in the AP2S1 gene (602242) on chromosome 19q13.;

Inheritance : Autosomal dominant;

Molecular basis : Caused by mutation in the calcium-sensing receptor gene (CASR, 601199.0001);

Laboratory abnormalities : Hypocalciuria; Hypercalcemia; Hypermagnesemia; Urinary calcium-creatinine ratio 0.01:1 supports diagnosis; Normal concentration of parathyroid hormone; Hypercalciuria (in some patients);

Prefixed ID : #145980;

Details


You can consult :


Nous contacter.
03/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.